Lower expression of ECM29 displayed a marginally longer relapse‐free survival time when all breast cancer cases were analyzed [hazard ratio (HR) = 1.26, log‐rank P = 8.5 × 10−5, n = 3,554; Fig 5H]. This evidence concerns the gene ECPAS and breast cancer.